BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25027069)

  • 1. Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile.
    Gilbreath JJ; Verma P; Abbott AN; Butler-Wu SM
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):13-8. PubMed ID: 25027069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.
    Putsathit P; Morgan J; Bradford D; Engelhardt N; Riley TV
    Pathology; 2015 Feb; 47(2):165-8. PubMed ID: 25551308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.
    Shin BM; Yoo SM; Shin WC
    Ann Lab Med; 2016 Mar; 36(2):131-7. PubMed ID: 26709260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.
    Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW
    Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
    Deak E; Miller SA; Humphries RM
    J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 3 automated real-time PCR (Xpert C. difficile assay, BD MAX Cdiff, and IMDx C. difficile for Abbott m2000 assay) for detecting Clostridium difficile toxin gene compared to toxigenic culture in stool specimens.
    Yoo J; Lee H; Park KG; Lee GD; Park YG; Park YJ
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):7-10. PubMed ID: 26081240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular methods in the diagnosis of Clostridium difficile infections: an update.
    Le Guern R; Herwegh S; Courcol R; Wallet F
    Expert Rev Mol Diagn; 2013 Sep; 13(7):681-92. PubMed ID: 24063396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
    Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
    J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative performance study of six commercial molecular assays for rapid detection of toxigenic Clostridium difficile.
    Paitan Y; Miller-Roll T; Adler A
    Clin Microbiol Infect; 2017 Aug; 23(8):567-572. PubMed ID: 28223147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
    Dalpke AH; Hofko M; Zorn M; Zimmermann S
    J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.
    Hirvonen JJ; Kaukoranta SS
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):1005-9. PubMed ID: 25616552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory.
    Zidarič V; Kotnik Kevorkijan B; Oresic N; Janezic S; Rupnik M
    J Med Microbiol; 2011 Aug; 60(Pt 8):1131-1136. PubMed ID: 21372187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection.
    Granato PA; Hansen G; Herding E; Chaudhuri S; Tang S; Garg SK; Rowell CR; Sickler JJ
    PLoS One; 2018; 13(7):e0200498. PubMed ID: 30040852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-laboratory comparison of two molecular methods for the detection of toxigenic Clostridium difficile.
    Halstead DC; Abid J; Sloan L; Meza D; Ramsey-Walker D; Hata DJ
    J Infect Dev Ctries; 2016 Jan; 10(1):62-7. PubMed ID: 26829538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Copan FecalSwab as Specimen Type for Use in Xpert C. difficile Assay.
    Mashock MJ; Faron ML; Buchan BW; Ledeboer NA
    J Clin Microbiol; 2017 Oct; 55(10):3123-3129. PubMed ID: 28794179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples.
    Doing KM; Hintz MS
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):8-13. PubMed ID: 22015321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
    Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
    J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.